Literature DB >> 8463414

Pulmonary platelet aggregates: possible cause of sudden peroperative death in adults undergoing liver transplantation.

E A Sankey1, J Crow, S V Mallett, R J Alcock, L More, A K Burroughs, K Rolles.   

Abstract

AIMS: To determine if massive pulmonary platelet thromboembolism is a common cause of peroperative death following liver transplantation; and to compare the incidence of this event with patients dying after non-transplantation procedures.
METHODS: Necropsy tissues from all patients dying within 10 days of operation during the past three and a half years were studied (six liver transplantations and 13 unrelated operations). Haematoxylin and eosin stained sections of all tissues were examined. Additional sections of lung tissue were immunostained for constituents of thrombus (fibrin and platelets).
RESULTS: At necropsy the lungs from all six liver transplant recipients were heavy with a rubbery texture and little oedema fluid. Those from non-transplantation patients appeared normal or very oedematous. Microscopic examination showed that there were numerous platelet aggregates occluding pulmonary capillaries in all six transplant recipients, but in only three of the non-transplant patients. These thrombi were numerous in patients dying during surgery and the number was underestimated in routine sections because of the surrounding capillary congestion. Detection was improved by immunostaining for platelets with factor XIIIA and platelet glyco-protein IIIa.
CONCLUSIONS: Massive platelet thromboembolism is a likely cause of death in patients dying unexpectedly following recent liver transplantation. Non-transplantation patients dying during surgery who show similar appearances usually have conditions known to have a high risk of thrombosis or embolism (cement hypotension syndrome and disseminated intravascular coagulation). The cause of this extensive platelet activation in liver transplant recipients is uncertain and may be multifactorial. The unusual rubbery consistency of the lungs on macroscopic examination could alert the pathologist to the underlying condition. Immunostaining for platelets improves the detection microscopically.

Entities:  

Mesh:

Year:  1993        PMID: 8463414      PMCID: PMC501174          DOI: 10.1136/jcp.46.3.222

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  The intra-operative use of trasylol (aprotinin) in liver transplantation.

Authors:  S V Mallett; D Cox; A K Burroughs; K Rolles
Journal:  Transpl Int       Date:  1991-12       Impact factor: 3.782

2.  The effect of intravenous injection of purified human tissue thromboplastin in rats.

Authors:  K E Giercksky; E Bjorklid; H Prydz
Journal:  Scand J Haematol       Date:  1976-04

3.  Transient pulmonary platelet sequestration during endotoxemia in dogs.

Authors:  F D Gutmann; V S Murthy; M T Wojciechowski; R M Wurm; R A Edzards
Journal:  Circ Shock       Date:  1987

4.  Effects of phospholipase C, a tissue thromboplastin inhibitor, on pulmonary microembolism after missile injury of the limb.

Authors:  I G Jansson; O Hetland; L M Rammer; H E Prydz; S E Lennquist
Journal:  J Trauma       Date:  1988-01

5.  Fibrin thrombi in the pulmonary microcirculation of dogs with gram-negative bacteremia.

Authors:  A C Groves; J Griffiths; F Y Leung; S C Naiman
Journal:  Surg Gynecol Obstet       Date:  1972-03

6.  The etiology of venous thrombi after aortic cross-clamping: an electron microscopic study.

Authors:  T P Ashford
Journal:  Surgery       Date:  1970-11       Impact factor: 3.982

7.  Pulmonary microembolism. A cause of morbidity and death after major vascular surgery.

Authors:  F W Blaisdell; R C Lim; J R Amberg; S H Choy; A D Hall; A N Thomas
Journal:  Arch Surg       Date:  1966-11

8.  Coexistent pulmonary and portal hypertension: morphologic and clinical features.

Authors:  B S Edwards; E K Weir; W D Edwards; J Ludwig; R K Dykoski; J E Edwards
Journal:  J Am Coll Cardiol       Date:  1987-12       Impact factor: 24.094

9.  Pulmonary microembolism during and after aortic cross-clamping in heparinized and non-heparinized pigs.

Authors:  S Bowald; B Gerdin
Journal:  Acta Chir Scand       Date:  1980

10.  Intravascular coagulation in autopsy cases with liver diseases.

Authors:  K Oka; K Tanaka
Journal:  Thromb Haemost       Date:  1979-08-31       Impact factor: 5.249

View more
  6 in total

Review 1.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 2.  Perioperative thrombotic complications in liver transplantation.

Authors:  Paolo Feltracco; Stefania Barbieri; Umberto Cillo; Giacomo Zanus; Marco Senzolo; Carlo Ori
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Platelet thromboembolism after lung transplantation.

Authors:  Carles Bravo; Joaquim Majó; Fernando Ruiz; Laura Muntaner; Víctor Monforte; Joan Solé; José Maestre; Ferran Morell; Antonio Roman
Journal:  J Transplant       Date:  2009-05-25

Review 4.  Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.

Authors:  Lynn A Fussner; Michael J Krowka
Journal:  Curr Gastroenterol Rep       Date:  2016-06

5.  [Role of splenectomy in the treatment of non-cirrhotic portal hypertension: about 3 cases].

Authors:  Mohamed Said Belhamidi; Salah Eddine Hammi; Mohamed Bouzroud; Mustapha Benmoussa; Abdelmounaim Ait Ali; Ahmed Bounaim
Journal:  Pan Afr Med J       Date:  2017-09-27

6.  Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs.

Authors:  Karla Chui Luan Lee; Luisa Baker; Susan Mallett; Anne Riddell; Pratima Chowdary; Hatim Alibhai; Yu-Mei Chang; Simon Priestnall; Giacomo Stanzani; Nathan Davies; Rajeshwar Mookerjee; Rajiv Jalan; Banwari Agarwal
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.